General Intensive Care Unit, University of Versailles Saint-Quentin en Yvelines, Garches, France.
Crit Care Med. 2011 Aug;39(8):1960-7. doi: 10.1097/CCM.0b013e31821b843b.
In critically ill patients, the assessment of neurologic function can be difficult because of the use of sedative agents. It is not known whether neurologic signs observed under sedation can predict short-term outcomes. The objective of this study was to assess whether abnormal brainstem responses within the first 24 hrs of sedation are associated with mortality and altered mental status postsedation.
Observational prospective study including an initial single-center and a subsequent multicenter study to develop and then validate the prognostic models.
Three mixed and two medical intensive care units.
Mechanically ventilated intensive care unit patients sedated with midazolam (± sufentanyl).
Neurologic examination including the Glasgow Coma Scale, the Assessment to Intensive Care Environment score, cranial nerve examination, response to noxious stimuli, and the cough reflex was performed.
Seventy-two patients were included in the initial group and 72 in a subsequent validation study. Neurologic responses were independent of sedative dose. Twenty-two patients in the development cohort and 21 (29%) in the validation group died within 28 days of inclusion. Adjusted for Simplified Acute Physiology Score II score, absent cough reflex was independently associated with 28-day mortality in the development (adjusted odds ratio [OR], 7.80; 95% confidence interval [CI], 2.00-30.4; p = .003) and validation groups (adjusted OR, 5.44; 95% CI, 1.35-22.0; p = .017). Absent oculocephalic response, adjusted for Simplified Acute Physiology Score II score, was independently associated with altered mental status after the withdrawal of sedation in the development (adjusted OR, 4.54; 95% CI, 1.34-15.4; p = .015) and validation groups (adjusted OR, 6.10; 95% CI, 1.18-25.5; p = .012).
Assessment of brainstem responses is feasible in sedated critically ill patients and loss of selected responses is predictive of mortality and altered mental status.
在危重病患者中,由于使用镇静剂,神经功能的评估可能较为困难。目前尚不清楚镇静下观察到的神经体征是否可以预测短期预后。本研究旨在评估镇静后 24 小时内异常脑干反应是否与死亡率和镇静后意识状态改变有关。
包括初始单中心和后续多中心研究的观察性前瞻性研究,以开发和验证预测模型。
三个混合和两个内科重症监护病房。
接受咪达唑仑(±舒芬太尼)镇静的机械通气重症监护病房患者。
进行神经系统检查,包括格拉斯哥昏迷量表、强化护理环境评估评分、颅神经检查、对有害刺激的反应和咳嗽反射。
72 例患者纳入初始组,72 例患者纳入后续验证研究。神经反应与镇静剂剂量无关。发展队列中有 22 例患者,验证组中有 21 例(29%)在纳入后 28 天内死亡。调整简化急性生理学评分 II 评分后,缺失咳嗽反射与发展组(调整后的优势比 [OR],7.80;95%置信区间 [CI],2.00-30.4;p=.003)和验证组(调整后的 OR,5.44;95% CI,1.35-22.0;p=.017)的 28 天死亡率独立相关。调整简化急性生理学评分 II 评分后,无眼头反射与镇静剂停药后意识状态改变独立相关,在发展组(调整后的 OR,4.54;95% CI,1.34-15.4;p=.015)和验证组(调整后的 OR,6.10;95% CI,1.18-25.5;p=.012)。
镇静危重患者的脑干反应评估是可行的,选择的反应丧失可预测死亡率和意识状态改变。